Jiangsu Apon Medical Technology Co Ltd Class A (300753) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jiangsu Apon Medical Technology Co Ltd Class A (300753) has a cash flow conversion efficiency ratio of -0.004x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-2.69 Million ≈ $-394.26K USD) by net assets (CN¥686.08 Million ≈ $100.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Jiangsu Apon Medical Technology Co Ltd C defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Jiangsu Apon Medical Technology Co Ltd Class A - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Jiangsu Apon Medical Technology Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Jiangsu Apon Medical Technology Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Apon Medical Technology Co Ltd Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Puma Biotechnology Inc
NASDAQ:PBYI
|
0.111x |
|
Shanghai Hi-Road Food Technology Co. Ltd.
SHE:300915
|
-0.003x |
|
Taiwan Steel Union Co Ltd
TW:6581
|
0.035x |
|
Hyundai Motor Securities Co. Ltd.
KO:001500
|
-0.045x |
|
Orthofix Medical Inc
NASDAQ:OFIX
|
-0.040x |
|
Wuhu Fuchun Dye and Weave Co.Ltd.
SHG:605189
|
0.362x |
|
Silvaco Group, Inc. Common Stock
NASDAQ:SVCO
|
-0.144x |
|
Wei Long Grape Wine Co Ltd
SHG:603779
|
-0.049x |
Annual Cash Flow Conversion Efficiency for Jiangsu Apon Medical Technology Co Ltd Class A (2014–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Apon Medical Technology Co Ltd Class A from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Jiangsu Apon Medical Technology Co Ltd C market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥707.86 Million ≈ $103.58 Million |
CN¥15.68 Million ≈ $2.29 Million |
0.022x | +166.18% |
| 2023-12-31 | CN¥697.20 Million ≈ $102.02 Million |
CN¥-23.34 Million ≈ $-3.41 Million |
-0.033x | +6.59% |
| 2022-12-31 | CN¥686.36 Million ≈ $100.44 Million |
CN¥-24.59 Million ≈ $-3.60 Million |
-0.036x | -252.95% |
| 2021-12-31 | CN¥780.52 Million ≈ $114.21 Million |
CN¥18.29 Million ≈ $2.68 Million |
0.023x | -79.20% |
| 2020-12-31 | CN¥739.84 Million ≈ $108.26 Million |
CN¥83.34 Million ≈ $12.20 Million |
0.113x | -2.02% |
| 2019-12-31 | CN¥674.88 Million ≈ $98.76 Million |
CN¥77.59 Million ≈ $11.35 Million |
0.115x | -9.73% |
| 2018-12-31 | CN¥613.39 Million ≈ $89.76 Million |
CN¥78.13 Million ≈ $11.43 Million |
0.127x | -46.95% |
| 2017-12-31 | CN¥279.38 Million ≈ $40.88 Million |
CN¥67.08 Million ≈ $9.82 Million |
0.240x | -9.59% |
| 2016-12-31 | CN¥229.59 Million ≈ $33.60 Million |
CN¥60.97 Million ≈ $8.92 Million |
0.266x | +1.41% |
| 2015-12-31 | CN¥145.40 Million ≈ $21.28 Million |
CN¥38.08 Million ≈ $5.57 Million |
0.262x | -36.37% |
| 2014-12-31 | CN¥81.37 Million ≈ $11.91 Million |
CN¥33.49 Million ≈ $4.90 Million |
0.412x | -- |
About Jiangsu Apon Medical Technology Co Ltd Class A
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. The company's principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers. Jiang… Read more